A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

  Maria Juárez ¹ AuthorId : 11346805
Author

  Nieves Diaz ¹ AuthorId : 11505935
Author

  Geoffrey I Johnston ¹ AuthorId : 11505936
Author

  Saba Nayar ² AuthorId : 1577591
Author

  Andrew Payne ¹ AuthorId : 11505937
Author

  Eric Helmer ¹ AuthorId : 11505938
Author

  Dionne Cain ¹ AuthorId : 11505939
Author

  Paulette Williams ³ AuthorId : 11505940
Author

  Wan Fai Ng ⁴ AuthorId : 1559935
Author

  Benjamin Fisher ² AuthorId : 1559930
Author

  Jacques-Eric Gottenberg ⁵ AuthorId : 117611
Author

  Giuliana Guggino ⁶ AuthorId : 11505941
Author

  Xavier Mariette ⁷ AuthorId : 417928
Author

  Marika Kvarnström ⁸ AuthorId : 1580534
Author

  Valérie Devauchelle-Pensec ^{9, 10} AuthorId : 1303661
Author Employer institution : Centre Hospitalier Régional Universitaire de Brest

  Jose Rosas ¹¹ AuthorId : 11505942
Author

  Juan Sanchez-Burson ¹² AuthorId : 11505943
Author

  Roberto Giacomelli ¹³ AuthorId : 1442401
Author

  Francesca Barone ² AuthorId : 1443191
Author IdHAL : francesca-barone

  Simon J Bowman ¹⁴ AuthorId : 1275542
Author